Callaghan Innovation Grant for Blis Technologies

NZX RELEASE 5th April 2018 Callaghan Innovation Grant for Blis Technologies Probiotics supplier, Blis Technologies (NZX: BLT) is pleased to advise that it has been approved for a Growth Grant from Callaghan Innovation of 20% rebate on qualifying Research and Development spend over three years. Blis has a proven track record in commercialising its Research and Development efforts having launched both BLIS K12TM and BLIS M18TM and has an ongoing focus of bringing new probiotic strains and finished products to the market. CEO Brian Watson said "Blis has a strong heritage of ground breaking research and commercialising new probiotic strains. The grant will help us add scale to our Research and Development investment to progress pipeline initiatives and future commercial opportunity for the company." Brian Watson Chief Executive Contact: +64 27 705 9133 End CA:00316410 For:BLT Type:MKTUPDTE Time:2018-04-05 10:55:10